DEERFIELD, Ill., April 15, 2025--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2025 financial results on Thursday ...

Northern blot, RNase protection and western blot demonstrated the induction of p21, MDM-2 and Bax expression in PXN100, but not PXN65. This was consistent with the p53 status of these tumours.

In trading on Wednesday, shares of Baxter International Inc (Symbol: BAX) crossed below their 200 day moving average of $34.36, changing hands as low as $33.98 per share. Baxter International Inc ...